evocatal GmbH

Activities: Ingredients

Trending Articles

  1. Lonza appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer As of 1 July 2025, Andreas joins Lonza’s Executive Committee as Chief Legal & Corporate Affairs Officer
  2. Famar Group acquires German sterile injectable production site from MiP Pharma The fill-finish facility will enhance Famar's footprint in aseptic and lyophilised therapeutic production, allowing the company to better serve its European clients
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    How to protect your workers with emergency showers In manufacturing environments where chemical exposure is a constant risk, the safety and well-being of your workforce should be a top priority, reports James Hamilton, Global...
  4. SCHOTT Pharma delivers strong second quarter of fiscal year 2025 SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today published its results for the second quarter of the fiscal year 2025
  5. Next generation module improves flow process automation Vapourtec unveils Reaction Controller and Datalogger module

Upcoming event

CPhI North America

20–22 May 2025 | Exhibition | Pennsylvania, US See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Design & Build

Looking for more sustainable processes

Moving to more sustainable and productive ways of manufacturing has to be the way forward for an industry facing higher costs and a squeeze on drug pricing. Susan Birks reports
Manufacturing

Rohnerchem and evocatal form biocatalytic processes partnership

With the aim of offering new routes to enantiomerically pure products
Ingredients

Evocatal releases C-C Coupling Kit

Offers enzymatic production of enantiopure 2-hydroxy-ketones
Ingredients

New enzymes from the deep Mediterranean

evocatal develops new biocatalysts from extreme marine environments
Subscribe now